Cogent Biosciences, Inc.
COGT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622229
In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Cogent Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 82 | 1 | 86 | +5 |
| Shares | 44.9M | 37.5K | 47.2M | +2.36M (+5.3%) |
| Value | $385.2M | $322.0K | $353.6M | −$31.3M (−8.1%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Cogent Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 2,651,754 | $19.9M | 1.69% |
| 5AM Venture Management, LLC | 711,412 | $5.33M | 1.16% |
| Citadel Advisors LLC | 65,501 | $491.0K | 0.00% |
| Woodline Partners LP | 36,783 | $276.0K | 0.00% |
| Barclays PLC | 34,142 | $257.0K | 0.00% |
| Parametric Portfolio Associates LLC | 28,131 | $211.0K | 0.00% |
| Renaissance Technologies LLC | 11,500 | $86.0K | 0.00% |
| Amalgamated Bank | 4,942 | $37.0K | 0.00% |
| Amalgamated Financial Corp. | 4,942 | $37.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,612 | $27.0K | 0.00% |
| UBS Group AG | 419 | $3.00K | 0.00% |
| IFP Advisors, Inc | 200 | $2.00K | 0.00% |
| Kayne Anderson Rudnick Investment Management LLC | 139 | $1.00K | 0.00% |
| CWM, LLC | 129 | $1.00K | 0.00% |
| Cubist Systematic Strategies, LLC | 90 | $1.00K | 0.00% |
Sold out (10)
Institutions that held Cogent Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Frazier Management LLC | 1,774,891 | $15.2M |
| Ra Capital Management, L.P. | 1,025,641 | $8.80M |
| Kynam Capital Management, LP | 150,000 | $1.29M |
| Franklin Resources Inc | 53,600 | $460.0K |
| Sender Co & Partners, Inc. | 48,861 | $419.0K |
| Bridgeway Capital Management, LLC | 39,690 | $341.0K |
| D. E. Shaw & Co., Inc. | 25,813 | $221.0K |
| Jump Financial, LLC | 16,200 | $139.0K |
| Squarepoint Ops LLC | 10,475 | $90.0K |
| Simplex Trading, LLC | 100 | $0 |
Not filed for Q1 2022 yet (1)
Institutions that held Cogent Biosciences, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| AlphaCentric Advisors LLC | 37,500 | $322.0K |